JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -12.95%14.68M | 27.88%36.03M | 9.55%25M | -5.98%16.86M | -30.39%7.2M | -27.06%28.17M | -8.26%22.82M | 18.09%17.94M | 54.94%10.34M | 20.41%38.63M |
Operating income | -12.95%14.68M | 27.88%36.03M | 9.55%25M | -5.98%16.86M | -30.39%7.2M | -27.06%28.17M | -8.26%22.82M | 18.09%17.94M | 54.94%10.34M | 20.41%38.63M |
Cost of sales | 19.28%-9.78M | -92.02%-25.12M | -63.83%-18.72M | -17.30%-12.12M | 19.29%-4.78M | 23.68%-13.08M | -41.68%-11.42M | -206.62%-10.33M | ---5.92M | ---17.14M |
Operating expenses | 19.28%-9.78M | -92.02%-25.12M | -63.83%-18.72M | -17.30%-12.12M | 19.29%-4.78M | 23.68%-13.08M | -41.68%-11.42M | -206.62%-10.33M | -5.92M | -17.14M |
Gross profit | 3.20%4.9M | -27.70%10.91M | -44.86%6.28M | -37.61%4.75M | -45.28%2.42M | -29.76%15.09M | -32.21%11.4M | -35.66%7.61M | 4.42M | 21.49M |
Selling expenses | -41.86%-6.71M | -106.33%-10.58M | -391.12%-7.43M | -845.96%-4.73M | -757.39%-1.76M | -1,621.87%-5.13M | -6,796.51%-1.51M | ---500.01K | ---205.27K | ---297.68K |
Administrative expenses | -40.15%-8.15M | -26.66%-16.8M | ---- | ---5.82M | ---- | ---13.27M | ---- | ---- | ---- | ---- |
Profit from asset sales | ---- | --2.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus | ---- | ---- | 158.25%894.23K | ---- | ---- | ---- | 44.95%-1.54M | 78.72%-432.18K | ---- | -184.39%-2.33M |
-Changes in the fair value of financial assets | ---- | ---- | 158.25%894.23K | ---- | ---- | ---- | 44.95%-1.54M | 78.72%-432.18K | ---- | -184.39%-2.33M |
Impairment and provision | 280.34%1.56M | 86.28%-1.58M | 109.06%564.78K | 85.25%-865.59K | -116.73%-783.99K | 18.50%-11.5M | 23.85%-6.23M | -364.06%-5.87M | 326.41%4.69M | -117.28%-14.11M |
-Other impairment is provision | 280.34%1.56M | 86.28%-1.58M | 109.06%564.78K | 85.25%-865.59K | -116.73%-783.99K | 18.50%-11.5M | 23.85%-6.23M | -364.06%-5.87M | 326.41%4.69M | -117.28%-14.11M |
Operating interest expense | ---- | ---- | 67.31%-886.22K | ---- | ---473.92K | ---3.66M | ---2.71M | ---1.86M | ---- | ---- |
Special items of operating profit | -74.15%186.2K | -29.48%1.39M | -40.15%-9.13M | 113.76%720.34K | 36.30%-1.82M | 120.27%1.98M | -39.03%-6.52M | -9.63%-5.23M | 22.29%-2.86M | 16.62%-9.75M |
Operating profit | -38.19%-8.22M | 14.14%-14.15M | -36.56%-9.71M | 5.49%-5.95M | -140.11%-2.42M | -229.52%-16.48M | -728.64%-7.11M | -267.71%-6.29M | 553.90%6.04M | -130.04%-5M |
Financing cost | 33.21%-494.7K | ---1.54M | ---- | ---740.64K | ---- | ---- | ---- | ---- | 48.25%-799.11K | 35.88%-4.3M |
Share of profits of associates | ---- | -56.02%-760.71K | ---760.71K | ---443.2K | ---165.9K | ---487.56K | ---- | ---- | ---- | ---- |
Earning before tax | -22.18%-8.71M | 3.02%-16.46M | -47.25%-10.47M | -13.32%-7.13M | -149.40%-2.59M | -82.50%-16.97M | -203.69%-7.11M | -521.83%-6.29M | 944.25%5.24M | -193.46%-9.3M |
Tax | -192.93%-992.97K | 103.48%325.68K | 85.86%-1.15M | 95.21%-338.97K | 86.41%-270.21K | -523.82%-9.35M | -1,429.97%-8.12M | -2,033.61%-7.08M | -1,766.09%-1.99M | 160.91%2.21M |
After-tax profit from continuing operations | -29.93%-9.7M | 38.71%-16.13M | 23.71%-11.62M | 44.14%-7.47M | -187.91%-2.86M | -271.08%-26.32M | -780.00%-15.23M | -1,253.05%-13.37M | 748.63%3.25M | -212.09%-7.09M |
Earning after tax | -29.93%-9.7M | 38.71%-16.13M | 23.71%-11.62M | 44.14%-7.47M | -187.91%-2.86M | -271.08%-26.32M | -780.00%-15.23M | -1,253.05%-13.37M | 748.63%3.25M | -212.09%-7.09M |
Minority profit | 37.23%15.88K | 2.23%71.61K | -47.05%35.14K | -88.88%11.58K | -100.58%-541 | 486.10%70.04K | 144.21%66.35K | 361.62%104.11K | 1,877,740.00%93.88K | ---18.14K |
Profit attributable to shareholders | -29.94%-9.72M | 38.60%-16.2M | 23.82%-11.65M | 44.49%-7.48M | -190.51%-2.86M | -273.02%-26.39M | -770.17%-15.3M | -1,285.08%-13.47M | 729.91%3.16M | -211.80%-7.07M |
Basic earnings per share | 84.19%-0.036 | 38.59%-0.06 | 24.56%-0.043 | -356.31%-0.2277 | -191.67%-0.011 | -272.90%-0.0977 | -714.29%-0.057 | -1,288.10%-0.0499 | 700.00%0.012 | -211.97%-0.0262 |
Diluted earnings per share | 84.19%-0.036 | 38.59%-0.06 | 24.56%-0.043 | -356.31%-0.2277 | -191.67%-0.011 | -272.90%-0.0977 | -714.29%-0.057 | -1,288.10%-0.0499 | 700.00%0.012 | -211.97%-0.0262 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | -- | -- | KPMG | -- | -- | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.